Results 91 to 100 of about 545,250 (204)

JAK inhibitors: a new choice for diabetes mellitus?

Diabetology & Metabolic Syndrome
Altered tyrosine kinase signaling is associated with a variety of diseases. Tyrosine kinases can be classified into two groups: receptor type and nonreceptor type. Nonreceptor-type tyrosine kinases are subdivided into Janus kinases (JAKs), focal adhesion
Mengjun Zhou, Qi Shen, Bo Li
doaj   +1 more source

Receptor Tyrosine Kinase [PDF]

, 2020
openaire   +1 more source

Autoregulation of the MET receptor tyrosine kinase by its intracellular juxtamembrane domain. [PDF]

Biochem J
Linossi EM, Espinoza CA, Estevam GO, Fraser JS, Jura N.   +4 more
europepmc   +1 more source

Cholesterol promotes the formation of dimers and oligomers of the receptor tyrosine kinase ROR1. [PDF]

J Biol Chem
Ward A, Baeza-Ballesteros LJ, Schuck R, García-Murria MJ, Lamichhane R, Mingarro I, Barrera FN.   +6 more
europepmc   +1 more source

Modulation of the Receptor Tyrosine Kinase TIE2/Tek Pathway by NRF2 Activation in Neurovascular Endothelial Cells. [PDF]

Int J Mol Sci
Cazalla E, García-Yagüe ÁJ, Pajares M, Jiménez-Villegas J, Escoll M, Rojo AI, Cuadrado A.   +6 more
europepmc   +1 more source

Targeting Oncogenic Activity and Signalling of Mutant Receptor Tyrosine Kinase FLT3. [PDF]

Cancers (Basel)
Dobrevski B, Willems H, Lossius-Cott C, Müller JP.   +3 more
europepmc   +1 more source

The Receptor Tyrosine Kinase Axl in (Advanced) Gastric Cancer-From Pathophysiology to Therapeutic Impact. [PDF]

Medicina (Kaunas)
Schreiner OD, Schreiner TG, Miron L, Ciobanu RC.   +3 more
europepmc   +1 more source

Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells [PDF]

, 2015
An, Qian, Birt, Matthew, Hafizi, Sassan, Pilkington, Geoffrey John, Vouri, Mikaella   +4 more
core   +2 more sources

Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026). [PDF]

Chin Med J (Engl)
Xie Z, Chen X, Gao R, Yang M, Han X, Sun Y, Shi Y.   +6 more
europepmc   +1 more source

The Landscape of Genomic Alterations in Receptor Tyrosine Kinase Pathways in Biliary Cancers: Implications for Targeted Therapies. [PDF]

J Gastrointest Cancer
Voutsadakis IA.
europepmc   +1 more source